Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts
- Faizal Z. Asumda
- , Nellie A. Campbell
- , Mohamed A. Hassan
- , Reza Fathi
- , Daniella F. Vasquez Rico
- , Melanie Kiem
- , Ethan V. Vang
- , Yo Han Kim
- , Xin Luo
- , Daniel R. O’Brien
- , Sarah A. Buhrow
- , Joel M. Reid
- , Michael J. Moore
- , Vered Katz Ben-Yair
- , Mark L. Levitt
- , Jennifer L. Leiting
- , Amro M. Abdelrahman
- , Xinli Zhu
- , Fabrice Lucien
- , Mark J. Truty
Research output: Contribution to journal › Article › peer-review